More than 12,000 new medicines in pipeline in 2023, up 31% from previous year: reportOf the 12,203 drugs in the pipeline, 5,319 were in Phase 1 while 4,979 were in Phase 2. In addition, there were 1,671 Phase 3 drugs and 234 in the pre-registration stage. Health Canada approves Moderna’s mRNA RSV vaccine, company saysThe company says it expects the RSV vaccine—called mRESVIA—to be available in early 2025. Nirsevimab assigned Schedule II status The injectable monoclonal antibody prevents respiratory syncytial virus in newborns and infants during their first RSV season and at-risk children during their second RSV season. Three new drug indications physicians and pharmacists should know about Get the info you need on these new indications as part of our drug news roundup for October. NEW IUD: Yanae Cu 380 Get the info you need on this new product, part of our drug news roundup for October. NEW DRUG: Ferinject for iron deficiency Get the info you need on this new product, part of our drug news roundup for October. New dosage form for Quillivant ER Oral Suspension Get the info you need on this new dosage for as part of our drug news roundup for October. Health Canada advisory: SGLT2 inhibitors and prolonged or incident diabetic ketoacidosis Take note of this Health Canada advisory as part of our October drug news update. NEW DRUG: Jubbonti approved for several indications Get the info you need on this new product, part of our drug news roundup for October. NEW DRUG: Wyost approved for two cancer-related indications Get the info you need on this new product, part of our drug news roundup for October. First Previous 3 4 5 6 7 Next Last
